Neuropeptide Therapy of Recent Onset Type 1 Diabetes
- First Posted Date
- 2016-07-01
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- Vanilloid Genetics Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02820558
- Locations
- 🇨🇦
Hospital for Sick Children, Toronto, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath